Dr. Moriarty is board certified in Internal, Pulmonary and Sleep Medicine. He has been serving Panama City since 1998. Since 1991, Dr. Moriarty has participated in over 70 clinical studies with 21 major sponsors. He has also served as conference lecturer for Pfizer, Boehringer Ingelheim, Abbott, Glaxo Wellcome, Astra Zeneca, Forest and the Bay County Medical Society in the areas of Community Acquired Pneumonia, Chronic Obstructive Lung Disease, and Asthma.
Dr. Moriarty serves as Principal Investigator and when appropriate, as Sub Investigator. He became an ACRP certified Principal Investigator via examination September 2010.
Dr. Tumiel is board certified in Internal Medicine and Gastroenterology. Dr. Tumiel has served as Principal Investigator over multiple Constipation Irritable Bowel Syndrome studies while working with ECRA. In addition to IBS studies, he currently serves as Principal Investigator over a Chronic Constipation study. Dr. Tumiel joined the ECRA team in 2001 and has been serving Panama City as a Gastroenterologist in private practice since 1995. His previous research experience includes studies with laboratory identification and medical management of Hepatitis C.
Dr. McKenzie is board certified in Internal, Pulmonary, and Sleep Medicine. Dr. McKenzie joined the ECRA team in 2009 as a Sub Investigator and continues this role on multiple pulmonary studies. His previous research experience includes a molecular study on AIDS and a case study researching the link between hypothyroxemia and cerebral palsy both at the University of South Alabama and an in vitro study investigating intracellular DHEA conducted at the University of Alabama Birmingham. Dr. McKenzie has been serving Panama City since 2005.
Binita V. Amin is board certified in Internal Medicine and board eligible in Asthma, Allergy and Immunology. She has been serving Panama City since 2006 and joined the ECRA team in 2010. She is participating as a Sub Investigator on pulmonary studies. Since 1999 Dr Amin has participated in 23 clinical studies with 12 major sponsors. She also has research publications on allergic rhinitis and asthma interrelationships, latex allergy in a healthy infant, and conversion disorder presenting as asthma and laryngeal edema.
Ms. Currie began her clinical research experience in 1996. She completed The Graduate Training Program in Clinical Investigation at The Schools of Medicine and Public Health at The Johns Hopkins University. During her tenure as a Research Associate at the University of Maryland and as a Research Coordinator at The Johns Hopkins Bayview Medical Center, she participated in nine studies in the areas of claudication, oncology, and weight management.
She has worked as the Panama City Site Director for Tampa Bay Medical Research and as the Director of Clinical Research for The Clinical Research Center of Northwest Florida. Since 2001, she has participated in greater than 50 primarily phase II and phase III trials in the therapeutic areas of Asthma, COPD, Overactive Bladder, Infectious Disease, Interventional Cardiology and Irritable Bowel Syndrome. Ms. Currie received her clinical research coordinator certificate from ACRP via examination in 2000.
ECRA also includes numerous support staff. Our staff is proficient in Remote Data Capture and electronic diaries. Each member of the ECRA lab staff is Hazmat certified. Our staff is HIPPA compliant, and knowledgeable of ICH guidelines and Good Clinical Practices. ECRA consistently meets and exceeds sponsor enrollment goals. Our site uses Study Manager. ECRA staff utilizes a patient database, MD referrals, flyer and brochure distribution, as well as print, website, FaceBook, radio and television media for patient recruitment. ECRA has a strong commitment to community involvement and service. Our Principal Investigators and Directors are frequent speakers at community seminars, lunch and learn events, fundraisers and participate in health fairs. We pride ourselves on being a company with a focus on patient education. We recognize the importance of our volunteers and understand that without our volunteers, there would be no new medications.